At Heron, we are unwavering in our commitment to improve the lives of patients. We aim to advance the therapeutic standard of care for patients through a portfolio of best-in-class therapies that bring together our innovative science and technologies with well-known pharmacology to deliver medicines that matter.
HRTX (Common Stock) |
|
| Exchange | NASDAQ CM (US Dollar) |
| Price | 0.35 |
| Change (%) | -0.0083 (-2.33%) |
| Volume | 4,078,353 |
| Data as of 10/02/26 4:00 pm EDT | |
Minimum 15 minutes delayed. Source: LSEG